ArticlePorcine health management2026
Epidemiological analysis, risk factors, and spatial-temporal clustering of classical swine fever virus in China.
Article in Porcine health management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundClassical Swine Fever (CSF), or swine cholera, is a highly acute, febrile, and contagious disease caused by the Classical Swine Fever virus (CSFV) in pigs.
resultsA total of 205,622 samples were collected from 689 pig farms defined as individual production units nationwide across 20 Chinese provinces/cities from January to December 2022. The results showed that at the sample level, the prevalence of CSFV was 0.25% (95% confidence interval (CI) 0.22% − 0.27%). At the pig farm level, the prevalence of CSFV was 5.08% (95% CI: 3.44% − 6.72%). The risk factors for CSFV infection in pig farms included geographic distribution, quarter, and herd category variables. Eight different temporal groups with a high prevalence of CSFV were also found in China, with the highest prevalence occurring from August to September 2022. Tissue samples and oropharyngeal/nasal swabs showed superior detection rates (1.00% and 0.34%, respectively) and are thus recommended for CSFV surveillance.
conclusionsIn conclusion, this data complements the existing studies on the Chinese CSFV positive rate, risk factors, and temporal clustering. Our findings identify high-risk periods (August – September 2022) and regions (Northwest China), providing targeted strategies for CSFV control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.